| Drug transfer across the blood‐brain barrier: correlation between in vitro and in vivo models MP Dehouck, P Jolliet‐Riant, F Brée, JC Fruchart, R Cecchelli, ... Journal of neurochemistry 58 (5), 1790-1797, 1992 | 350 | 1992 |
| Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey C Victorri‐Vigneau, E Dailly, G Veyrac, P Jolliet British journal of clinical pharmacology 64 (2), 198-209, 2007 | 238 | 2007 |
| Antidepressant-like effects in various mice strains in the forced swimming test DJP David, CE Renard, P Jolliet, M Hascoët, M Bourin Psychopharmacology 166, 373-382, 2003 | 209 | 2003 |
| An overview of the clinical pharmacokinetics of x-ray contrast media M Bourin, P Jolliet, F Ballereau Clinical pharmacokinetics 32, 180-193, 1997 | 155 | 1997 |
| Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor Antagonist A Pagliara, B Testa, PA Carrupt, P Jolliet, C Morin, D Morin, S Urien, ... Journal of medicinal chemistry 41 (6), 853-863, 1998 | 146 | 1998 |
| Drug transfer across the blood‐brain barrier and improvement of brain delivery P Jolliet‐Riant, JP Tillement Fundamental & clinical pharmacology 13 (1), 16-26, 1999 | 138 | 1999 |
| Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. P Jolliet, N Simon, J Barre, JY Pons, M Boukef, BJ Paniel, JP Tillement International journal of clinical pharmacology and therapeutics 36 (9), 506-509, 1998 | 120 | 1998 |
| Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect? C Joyau, G Veyrac, V Dixneuf, P Jolliet Clinical and Experimental Rheumatology-Incl Supplements 30 (5), 700, 2012 | 112 | 2012 |
| Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice DJP David, M Bourin, G Jego, C Przybylski, P Jolliet, AM Gardier British journal of pharmacology 140 (6), 1128-1136, 2003 | 103 | 2003 |
| Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and … E Dailly, F Raffi, P Jolliet Journal of chromatography B 813 (1-2), 353-358, 2004 | 100 | 2004 |
| A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study E Dailly, R Bouquié, G Deslandes, P Jolliet, R Le Floch Journal of Chromatography B 879 (15-16), 1137-1142, 2011 | 96 | 2011 |
| Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies P Pottier, JB Hardouin, S Lejeune, P Jolliet, B Gillet, B Planchon Thrombosis research 124 (4), 468-476, 2009 | 92 | 2009 |
| An update on zolpidem abuse and dependence C Victorri-Vigneau, M Gérardin, M Rousselet, M Guerlais, ... Journal of addictive diseases 33 (1), 15-23, 2014 | 82 | 2014 |
| High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the … E Dailly, L Thomas, MF Kergueris, P Jolliet, M Bourin Journal of Chromatography B: Biomedical Sciences and Applications 758 (2 …, 2001 | 80 | 2001 |
| A liquid chromatography–tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz … J Martin, G Deslandes, E Dailly, C Renaud, V Reliquet, F Raffi, P Jolliet Journal of Chromatography B 877 (27), 3072-3082, 2009 | 74 | 2009 |
| A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross‐reactivities A Pipet, G Veyrac, F Wessel, P Jolliet, A Magnan, P Demoly, PJ Bousquet Clinical & Experimental Allergy 41 (11), 1602-1608, 2011 | 73 | 2011 |
| Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice DJP David, M Bourin, M Hascoët, MC Colombel, GB Baker, P Jolliet Psychopharmacology 153, 443-449, 2001 | 72 | 2001 |
| Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery P Jolliet, N Simon, F Brée, S Urien, A Pagliara, PA Carrupt, B Testa, ... Pharmaceutical research 14, 650-656, 1997 | 68 | 1997 |
| Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria N Simon, P Jolliet, C Morin, R Zini, S Urien, JP Tillement FEBS letters 435 (1), 25-28, 1998 | 67 | 1998 |
| Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice BÁN Dhonnchadha, M Hascoët, P Jolliet, M Bourin Behavioural brain research 147 (1-2), 175-184, 2003 | 66 | 2003 |
